Using the four Biotechnology Uses and Development surveys of Statistics Canada, we analyse the relative importance of funding and support as well as collaboration and contracting, R&D and IP strategies on the propensity to patent of Canadian biotechnology firms. Our model accounts for the...

After presenting the history, the evolution and the content of innovation surveys, we discuss the characteristics of the data they contain and the challenge they pose to the analyst and the econometrician. We document the two uses that have been made of these data: the construction of...

From cross-sectional data of 460 firms that responded to both the 1988 and the 1992 Dutch innovation surveys we have reexamined the causality direction between R&D and patents, using data on contemporaneous and four-year lagged patent applications and R&D expenditures. The two equations have...

The aim of this study is to measure the cost of capital of the Canadian knowledge based firms in order to compare it with other Canadian firms' cost of capital. To determine which firms are based on knowledge, we use the research and development ratio. Estimations are achieved with several...

This paper addresses the question of whether R&D should be carried out by an independent research unit or be produced in-house by the firm marketing the innovation. We define two organizational structures. In an integrated structure, the firm that markets the innovation also carries out and...

This study examines the effectiveness of R&D tax incentives using an unbalanced panel of 434 Canadian firms. Not all firms in the sample are R&D performers. A B-index summarizing the various tax incentives for R&D is constructed for each firm, taking into account individual ceilings in the use...